Neha Patel

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

J. B. Kuemmerle‐Deschner, É. Hachulla, R. Cartwright et al. · Annals of the Rheumatic Diseases · 2011 · 212 citations

Different Pathways Act Downstream of the CEP Peptide Receptor CRA2 to Regulate Lateral Root and Nodule Development

Nadiatul A. Mohd‐Radzman, Carole Laffont, Ariel Ivanovici et al. · PLANT PHYSIOLOGY · 2016 · 138 citations · Full text

Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study

Isabelle Koné‐Paut, Helen J. Lachmann, Jasmin Kuemmerle‐Deschner et al. · Arthritis Research & Therapy · 2011 · 133 citations · Full text

Characterization of a CNS penetrant, selective M₁muscarinic receptor agonist, 77‐LH‐28‐1

Christopher J. Langmead, Nigel Austin, Clive L. Branch et al. · British Journal of Pharmacology · 2008 · 131 citations · Full text

Activation of TRPML1 Clears Intraneuronal Aβ in Preclinical Models of HIV Infection

Mihyun Bae, Neha Patel, Haoxing Xu et al. · Journal of Neuroscience · 2014 · 105 citations · Full text

Immunology, Immunodominance, Human Immunodeficiency Virus +23